These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 14745917

  • 1. Valproate-induced neural tube defects in folate-binding protein-2 (Folbp2) knockout mice.
    Spiegelstein O, Merriweather MY, Wicker NJ, Finnell RH.
    Birth Defects Res A Clin Mol Teratol; 2003 Dec; 67(12):974-8. PubMed ID: 14745917
    [Abstract] [Full Text] [Related]

  • 2. Arsenic-induced congenital malformations in genetically susceptible folate binding protein-2 knockout mice.
    Wlodarczyk B, Spiegelstein O, Gelineau-van Waes J, Vorce RL, Lu X, Le CX, Finnell RH.
    Toxicol Appl Pharmacol; 2001 Dec 15; 177(3):238-46. PubMed ID: 11749123
    [Abstract] [Full Text] [Related]

  • 3. Folic acid and pantothenic acid protection against valproic acid-induced neural tube defects in CD-1 mice.
    Dawson JE, Raymond AM, Winn LM.
    Toxicol Appl Pharmacol; 2006 Mar 01; 211(2):124-32. PubMed ID: 16112698
    [Abstract] [Full Text] [Related]

  • 4. Myo-inositol enhances teratogenicity of valproic acid in the mouse.
    Massa V, Wlodarczyk B, Giavini E, Finnell RH.
    Birth Defects Res A Clin Mol Teratol; 2006 Mar 01; 76(3):200-4. PubMed ID: 16511884
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cardiovascular abnormalities in Folr1 knockout mice and folate rescue.
    Zhu H, Wlodarczyk BJ, Scott M, Yu W, Merriweather M, Gelineau-van Waes J, Schwartz RJ, Finnell RH.
    Birth Defects Res A Clin Mol Teratol; 2007 Apr 01; 79(4):257-68. PubMed ID: 17286298
    [Abstract] [Full Text] [Related]

  • 7. Effect of supplemental folic acid on valproic acid-induced embryotoxicity and tissue zinc levels in vivo.
    Hansen DK, Grafton TF, Dial SL, Gehring TA, Siitonen PH.
    Teratology; 1995 Nov 01; 52(5):277-85. PubMed ID: 8838251
    [Abstract] [Full Text] [Related]

  • 8. Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development.
    Piedrahita JA, Oetama B, Bennett GD, van Waes J, Kamen BA, Richardson J, Lacey SW, Anderson RG, Finnell RH.
    Nat Genet; 1999 Oct 01; 23(2):228-32. PubMed ID: 10508523
    [Abstract] [Full Text] [Related]

  • 9. Anticonvulsant profile and teratogenic evaluation of potent new analogues of a valproic acid urea derivative in NMRI mice.
    Okada A, Noyori H, Yagen B, Shimshoni JA, Bialer M, Fujiwara M.
    Birth Defects Res B Dev Reprod Toxicol; 2009 Oct 01; 86(5):394-401. PubMed ID: 19830722
    [Abstract] [Full Text] [Related]

  • 10. Arsenic-induced gene expression changes in the neural tube of folate transport defective mouse embryos.
    Wlodarczyk BJ, Cabrera RM, Hill DS, Bozinov D, Zhu H, Finnell RH.
    Neurotoxicology; 2006 Jul 01; 27(4):547-57. PubMed ID: 16620997
    [Abstract] [Full Text] [Related]

  • 11. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
    Ornoy A.
    Reprod Toxicol; 2009 Jul 01; 28(1):1-10. PubMed ID: 19490988
    [Abstract] [Full Text] [Related]

  • 12. Amidic modification of valproic acid reduces skeletal teratogenicity in mice.
    Okada A, Kurihara H, Aoki Y, Bialer M, Fujiwara M.
    Birth Defects Res B Dev Reprod Toxicol; 2004 Feb 01; 71(1):47-53. PubMed ID: 14991910
    [Abstract] [Full Text] [Related]

  • 13. Teratogenicity of valproate conjugates with anticonvulsant activity in mice.
    Spiegelstein O, Chatterjie N, Alexander G, Finnell RH.
    Epilepsy Res; 2003 Dec 01; 57(2-3):145-52. PubMed ID: 15013055
    [Abstract] [Full Text] [Related]

  • 14. Hydroxamic acid and fluorinated derivatives of valproic acid: anticonvulsant activity, neurotoxicity and teratogenicity.
    Gravemann U, Volland J, Nau H.
    Neurotoxicol Teratol; 2008 Dec 01; 30(5):390-4. PubMed ID: 18455366
    [Abstract] [Full Text] [Related]

  • 15. Embryonic development in the reduced folate carrier knockout mouse is modulated by maternal folate supplementation.
    Gelineau-van Waes J, Heller S, Bauer LK, Wilberding J, Maddox JR, Aleman F, Rosenquist TH, Finnell RH.
    Birth Defects Res A Clin Mol Teratol; 2008 Jul 01; 82(7):494-507. PubMed ID: 18383508
    [Abstract] [Full Text] [Related]

  • 16. Identification of early-responsive genes correlated to valproic acid-induced neural tube defects in mice.
    Okada A, Kushima K, Aoki Y, Bialer M, Fujiwara M.
    Birth Defects Res A Clin Mol Teratol; 2005 Apr 01; 73(4):229-38. PubMed ID: 15799026
    [Abstract] [Full Text] [Related]

  • 17. Ribonucleotide reductase subunit R1: a gene conferring sensitivity to valproic acid-induced neural tube defects in mice.
    Craig JC, Bennett GD, Miranda RC, Mackler SA, Finnell RH.
    Teratology; 2000 Apr 01; 61(4):305-13. PubMed ID: 10716750
    [Abstract] [Full Text] [Related]

  • 18. Hypothesis: folate-responsive neural tube defects and neurocristopathies.
    Antony AC, Hansen DK.
    Teratology; 2000 Jul 01; 62(1):42-50. PubMed ID: 10861632
    [Abstract] [Full Text] [Related]

  • 19. Pantothenic acid decreases valproic acid-induced neural tube defects in mice (I).
    Sato M, Shirota M, Nagao T.
    Teratology; 1995 Sep 01; 52(3):143-8. PubMed ID: 8638254
    [Abstract] [Full Text] [Related]

  • 20. Embryonic development of folate binding protein-1 (Folbp1) knockout mice: Effects of the chemical form, dose, and timing of maternal folate supplementation.
    Spiegelstein O, Mitchell LE, Merriweather MY, Wicker NJ, Zhang Q, Lammer EJ, Finnell RH.
    Dev Dyn; 2004 Sep 01; 231(1):221-31. PubMed ID: 15305303
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.